Company Encyclopedia
View More
name
Therapeutic Solutions International, Inc.
TSOI.US
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.
4.707 T
TSOI.USMarket value -Rank by Market Cap -/-

Financial Score

31/12/2025 Update
D
PharmaceuticalsIndustry
Industry Ranking172/186
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-189.11%E
    • Profit Margin-2824.94%E
    • Gross Margin77.58%A
  • Growth ScoreC
    • Revenue YoY1.89%C
    • Net Profit YoY14.48%C
    • Total Assets YoY3.63%C
    • Net Assets YoY28.44%A
  • Cash ScoreC
    • Cash Flow Margin-3.54%D
    • OCF YoY1.89%C
  • Operating ScoreE
    • Turnover0.02E
  • Debt ScoreC
    • Gearing Ratio53.29%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --